Global Surgical Treatment of Dermatophytosis Industry

2023-2029 Global Surgical Treatment of Dermatophytosis Industry Research & Trends Analysis Report

Global Surgical Treatment of Dermatophytosis Industry

2023-2029 Global Surgical Treatment of Dermatophytosis Industry Research & Trends Analysis Report

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to the research report, the global market for Surgical Treatment of Dermatophytosis should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Surgical Treatment of Dermatophytosis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Surgical Treatment of Dermatophytosis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Dermatophytic Onychomycosis Therapeutic Lasers segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Surgical Treatment of Dermatophytosis include Bausch Health, Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd. and Medimetriks Pharmaceuticals, Inc., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Surgical Treatment of Dermatophytosis. Report Highlights:

(1) Global Surgical Treatment of Dermatophytosis market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Surgical Treatment of Dermatophytosis market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Surgical Treatment of Dermatophytosis market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Surgical Treatment of Dermatophytosis segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Surgical Treatment of Dermatophytosis segment by type and by application and regional segment by type and by application.

(6) Surgical Treatment of Dermatophytosis industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Dermatophytic Onychomycosis Therapeutic Lasers

Photodynamic Therapy

Market segment by application, can be divided into

Hospital

Clinic

Others

Market segment by players, this report covers

Bausch Health

Galderma S.A.

Novartis AG

Pfizer, Inc.

Moberg Pharma AB

Bayer AG

Dr. Reddy’s Laboratories Ltd.

Cipla Ltd.

Medimetriks Pharmaceuticals, Inc.

Sanofi S.A.

GlaxoSmithKline Plc.

Teva Pharmaceutical industries Ltd.

Cardinal Health Inc.

Viatris Inc.

Almirall, S.A

1 Market Overview

1.1 Product Overview and Scope of Surgical Treatment of Dermatophytosis

1.2 Global Surgical Treatment of Dermatophytosis Market Size and Forecast

1.3 China Surgical Treatment of Dermatophytosis Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Surgical Treatment of Dermatophytosis Share in Global Market, 2018-2029

1.4.2 Surgical Treatment of Dermatophytosis Market Size: China VS Global, 2018-2029

1.5 Surgical Treatment of Dermatophytosis Market Dynamics

1.5.1 Surgical Treatment of Dermatophytosis Market Drivers

1.5.2 Surgical Treatment of Dermatophytosis Market Restraints

1.5.3 Surgical Treatment of Dermatophytosis Industry Trends

1.5.4 Surgical Treatment of Dermatophytosis Industry Policy

2 Global Competitive Situation by Company

2.1 Global Surgical Treatment of Dermatophytosis Revenue by Company (2018-2023)

2.2 Global Surgical Treatment of Dermatophytosis Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Surgical Treatment of Dermatophytosis Concentration Ratio

2.4 Global Surgical Treatment of Dermatophytosis Mergers & Acquisitions, Expansion Plans

2.5 Global Surgical Treatment of Dermatophytosis Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Surgical Treatment of Dermatophytosis Revenue by Company (2018-2023)

3.2 China Surgical Treatment of Dermatophytosis Surgical Treatment of Dermatophytosis Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Surgical Treatment of Dermatophytosis, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Surgical Treatment of Dermatophytosis Industry Chain

4.2 Surgical Treatment of Dermatophytosis Upstream Analysis

4.3 Surgical Treatment of Dermatophytosis Midstream Analysis

4.4 Surgical Treatment of Dermatophytosis Downstream Analysis

5 Sights by Type

5.1 Surgical Treatment of Dermatophytosis Classification

5.1.1 Dermatophytic Onychomycosis Therapeutic Lasers

5.1.2 Photodynamic Therapy

5.2 By Type, Global Surgical Treatment of Dermatophytosis Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Surgical Treatment of Dermatophytosis Revenue, 2018-2029

6 Sights by Application

6.1 Surgical Treatment of Dermatophytosis Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Others

6.2 By Application, Global Surgical Treatment of Dermatophytosis Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Surgical Treatment of Dermatophytosis Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Surgical Treatment of Dermatophytosis Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Surgical Treatment of Dermatophytosis Market Size, 2018-2029

7.3 North America

7.3.1 North America Surgical Treatment of Dermatophytosis Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Surgical Treatment of Dermatophytosis Market Size Market Share

7.4 Europe

7.4.1 Europe Surgical Treatment of Dermatophytosis Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Surgical Treatment of Dermatophytosis Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Surgical Treatment of Dermatophytosis Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Surgical Treatment of Dermatophytosis Market Size Market Share

7.6 South America

7.6.1 South America Surgical Treatment of Dermatophytosis Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Surgical Treatment of Dermatophytosis Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Surgical Treatment of Dermatophytosis Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.3.2 By Company, U.S. Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.4.2 By Company, Europe Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.5.2 By Company, China Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.5.3 By Type, China Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.6.2 By Company, Japan Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.7.2 By Company, South Korea Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.9.2 By Company, India Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.9.3 By Type, India Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Surgical Treatment of Dermatophytosis Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Surgical Treatment of Dermatophytosis Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Bausch Health

9.1.1 Bausch Health Company Information, Head Office, Market Area and Industry Position

9.1.2 Bausch Health Company Profile and Main Business

9.1.3 Bausch Health Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.1.4 Bausch Health Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.1.5 Bausch Health Recent Developments

9.2 Galderma S.A.

9.2.1 Galderma S.A. Company Information, Head Office, Market Area and Industry Position

9.2.2 Galderma S.A. Company Profile and Main Business

9.2.3 Galderma S.A. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.2.4 Galderma S.A. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.2.5 Galderma S.A. Recent Developments

9.3 Novartis AG

9.3.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.3.2 Novartis AG Company Profile and Main Business

9.3.3 Novartis AG Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.3.4 Novartis AG Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.3.5 Novartis AG Recent Developments

9.4 Pfizer, Inc.

9.4.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

9.4.2 Pfizer, Inc. Company Profile and Main Business

9.4.3 Pfizer, Inc. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.4.4 Pfizer, Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.4.5 Pfizer, Inc. Recent Developments

9.5 Moberg Pharma AB

9.5.1 Moberg Pharma AB Company Information, Head Office, Market Area and Industry Position

9.5.2 Moberg Pharma AB Company Profile and Main Business

9.5.3 Moberg Pharma AB Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.5.4 Moberg Pharma AB Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.5.5 Moberg Pharma AB Recent Developments

9.6 Bayer AG

9.6.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

9.6.2 Bayer AG Company Profile and Main Business

9.6.3 Bayer AG Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.6.4 Bayer AG Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.6.5 Bayer AG Recent Developments

9.7 Dr. Reddy’s Laboratories Ltd.

9.7.1 Dr. Reddy’s Laboratories Ltd. Company Information, Head Office, Market Area and Industry Position

9.7.2 Dr. Reddy’s Laboratories Ltd. Company Profile and Main Business

9.7.3 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.7.4 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.7.5 Dr. Reddy’s Laboratories Ltd. Recent Developments

9.8 Cipla Ltd.

9.8.1 Cipla Ltd. Company Information, Head Office, Market Area and Industry Position

9.8.2 Cipla Ltd. Company Profile and Main Business

9.8.3 Cipla Ltd. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.8.4 Cipla Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.8.5 Cipla Ltd. Recent Developments

9.9 Medimetriks Pharmaceuticals, Inc.

9.9.1 Medimetriks Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 Medimetriks Pharmaceuticals, Inc. Company Profile and Main Business

9.9.3 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.9.4 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.9.5 Medimetriks Pharmaceuticals, Inc. Recent Developments

9.10 Sanofi S.A.

9.10.1 Sanofi S.A. Company Information, Head Office, Market Area and Industry Position

9.10.2 Sanofi S.A. Company Profile and Main Business

9.10.3 Sanofi S.A. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.10.4 Sanofi S.A. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.10.5 Sanofi S.A. Recent Developments

9.11 GlaxoSmithKline Plc.

9.11.1 GlaxoSmithKline Plc. Company Information, Head Office, Market Area and Industry Position

9.11.2 GlaxoSmithKline Plc. Company Profile and Main Business

9.11.3 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.11.4 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.11.5 GlaxoSmithKline Plc. Recent Developments

9.12 Teva Pharmaceutical industries Ltd.

9.12.1 Teva Pharmaceutical industries Ltd. Company Information, Head Office, Market Area and Industry Position

9.12.2 Teva Pharmaceutical industries Ltd. Company Profile and Main Business

9.12.3 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.12.4 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.12.5 Teva Pharmaceutical industries Ltd. Recent Developments

9.13 Cardinal Health Inc.

9.13.1 Cardinal Health Inc. Company Information, Head Office, Market Area and Industry Position

9.13.2 Cardinal Health Inc. Company Profile and Main Business

9.13.3 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.13.4 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.13.5 Cardinal Health Inc. Recent Developments

9.14 Viatris Inc.

9.14.1 Viatris Inc. Company Information, Head Office, Market Area and Industry Position

9.14.2 Viatris Inc. Company Profile and Main Business

9.14.3 Viatris Inc. Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.14.4 Viatris Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.14.5 Viatris Inc. Recent Developments

9.15 Almirall, S.A

9.15.1 Almirall, S.A Company Information, Head Office, Market Area and Industry Position

9.15.2 Almirall, S.A Company Profile and Main Business

9.15.3 Almirall, S.A Surgical Treatment of Dermatophytosis Models, Specifications and Application

9.15.4 Almirall, S.A Surgical Treatment of Dermatophytosis Revenue and Gross Margin, 2018-2023

9.15.5 Almirall, S.A Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Surgical Treatment of Dermatophytosis Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why are some of the most well-known companies left out of the Global Surgical Treatment of Dermatophytosis Market study?
The Global Surgical Treatment of Dermatophytosis study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
How big is the Global Surgical Treatment of Dermatophytosis Market by 2030?
It is expected that the Global Surgical Treatment of Dermatophytosis Market will reach USD XX million by 2030.
What are the advantages of the Global Surgical Treatment of Dermatophytosis Market research study?
The Global Surgical Treatment of Dermatophytosis Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
What does the future hold for the Global Surgical Treatment of Dermatophytosis Industry?
This latest research publication on the Global Surgical Treatment of Dermatophytosis Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.